A liver peptide composition for improving liver metabolic capacity

By combining liver peptides LLVF and LVF in a specific ratio, the problem of limited efficacy and dosage form of existing liver metabolism products has been solved. This has achieved comprehensive and efficient improvement of liver metabolism and adaptation to multiple routes of administration, thereby enhancing the liver's ability to metabolize alcohol, fat and detoxify.

CN122163759APending Publication Date: 2026-06-09HANGZHOU BAIBEIYOU NUTRITIONAL FOOD CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
HANGZHOU BAIBEIYOU NUTRITIONAL FOOD CO LTD
Filing Date
2026-04-14
Publication Date
2026-06-09

AI Technical Summary

Technical Problem

Existing liver metabolism improvement products have limited effects, dosage forms, and insufficient bioavailability. They cannot simultaneously improve alcohol metabolism, fat metabolism, and detoxification capabilities, and also have side effects.

Method used

By combining liver peptides LLVF and LVF with specific amino acid sequences in a specific ratio, along with pharmaceutically acceptable excipients, and delivering them through multiple routes of administration, they can form dosage forms such as oral, injectable, and topical formulations, thereby improving liver metabolic capacity.

Benefits of technology

It significantly enhances the liver's ability to metabolize alcohol, fat, and detoxify; it is compatible with various dosage forms; it has a high safety profile; it overcomes the limitations of existing products; and it provides a comprehensive solution for improving liver metabolism.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122163759A_ABST
    Figure CN122163759A_ABST
Patent Text Reader

Abstract

This invention discloses a liver peptide composition for enhancing liver metabolism, belonging to the technical field of liver peptide compositions. It includes liver peptides with the amino acid sequence LLVF and LVF. When liver peptides LLVF and LVF with specific amino acid sequences are combined in a specific ratio, they can synergistically enhance alcohol metabolism, lipid metabolism, and detoxification capabilities. Furthermore, when combined with different pharmaceutically acceptable excipients, it can be adapted to various routes of administration and dosage forms, solving the problems of existing products such as single efficacy, limited dosage forms, and insufficient bioavailability.
Need to check novelty before this filing date? Find Prior Art

Claims

1. A liver peptide composition for enhancing liver metabolic capacity, characterized in that, This includes liver peptides with the amino acid sequence LLVF and liver peptides with the amino acid sequence LVF.

2. The liver peptide composition for improving liver metabolic capacity according to claim 1, characterized in that, The mass ratio of LLVF to LVF is 1:(1~5).

3. The liver peptide composition for improving liver metabolic capacity according to claim 1, characterized in that, The hepateptide composition also includes one or more pharmaceutically acceptable excipients.

4. The liver peptide composition for improving liver metabolic capacity according to claim 3, characterized in that, The composition is intended for delivery to the human body via oral, injectable, mucosal, transdermal, or topical administration.

5. The liver peptide composition for improving liver metabolic capacity according to claim 4, characterized in that, The composition is available in oral, injectable, topical, or mucosal formulations.

6. The use of the hepateptide composition according to any one of claims 1-5 in the preparation of products that enhance liver metabolic capacity.

7. The application according to claim 6, characterized in that, The liver's metabolic capacity includes its ability to metabolize alcohol, fat, and detoxify.

8. The application according to claim 6, characterized in that, The products include food or medicine.

9. A drug for improving liver metabolic capacity, characterized in that, Includes the liver peptide composition according to any one of claims 1-5.

10. A food product for improving liver metabolic capacity, characterized in that, Includes the liver peptide composition according to any one of claims 1-5.